No, Wegovy isn’t involved in a class-action lawsuit. However, it is one of the glucagon-like peptide (GLP-1) receptor agonist drugs that are a part of MDL 3094 IN RE: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION.
The plaintiffs of these lawsuits claim that the manufacturers of these medications failed to warn users about the serious health complications caused by said drugs. As of February 2025, there are over 1,300 lawsuits involved in MDL 3094.
If you’ve been diagnosed with gastroparesis, vision loss, or bowel obstruction after a round of Wegovy treatment, you might be eligible for compensation. We suggest you reach out to our team so we can assess your case and determine if it’s eligible for a claim. If we determine that it’s eligible, we’ll put you in touch with an expert attorney immediately.